Caredx, INC Form 4 insider transactions

CareDx Chief Commercial Officer Jessica Meng reported the acquisition of restricted stock units and performance-based shares, alongside a disposition for tax withholding.

CareDx, Inc. Chief Financial Officer Nathan Smith reported significant acquisitions of restricted stock units and performance-based restricted stock units, alongside a tax-related share disposition.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reported the acquisition of restricted stock units and performance-based units, alongside tax-related dispositions and a sale under a 10b5-1 trading plan.

CareDx, Inc. CEO John Walter Hanna JR reported the acquisition of 200,132 shares through RSU and PRSU awards, alongside a disposition of 13,694 shares for tax withholding.

CareDx Inc. President and CEO John Walter Hanna Jr. sold common stock totaling 19,480 shares in January 2026 under a pre-arranged Rule 10b5-1 trading plan.

CareDx Inc. President and CEO, John Walter Hanna Jr., sold 10,156 shares of common stock on January 15, 2026, under a pre-arranged 10b5-1 trading plan.

CareDx, Inc. Director Michael Goldberg received an automatic quarterly grant of 1,492 shares of common stock as non-employee director compensation.

CareDx Secretary and General Counsel Jeffrey Adam Novack sold 7,293 shares of common stock on December 4, 2025, under a pre-arranged 10b5-1 trading plan.

Jeffrey Adam Novack, CareDx's Secretary and General Counsel, reported the sale of 2,688 shares of common stock at $15.5219 per share, executed under a Rule 10b5-1 trading plan.

CareDx Secretary and General Counsel Jeffrey Adam Novack disposed of 2,152 shares of common stock to cover tax obligations related to restricted stock unit vesting.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reported a future disposition of 2,872 common shares to cover tax liabilities from restricted stock unit vesting.

CareDx, Inc. Director Suresh Gunasekaran was granted 27,453 restricted stock units, vesting over three years.

CareDx, Inc. Director Michael Goldberg received an automatic grant of 1,753 shares of common stock as part of his non-employee director compensation.

CareDx, Inc.'s Chief Commercial Officer, Jessica Meng, disposed of 4,703 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

CareDx Chief Operating Officer Keith Kennedy reported the disposition of 7,987 common shares for tax withholding purposes at a price of $13.53 per share.

CareDx Director George Bickerstaff will acquire 29,136 common shares by exercising stock options at $7.96 per share on September 11, 2025, increasing his direct ownership.

CareDx, Inc. Chief Financial Officer Nathan Smith was granted 42,000 restricted stock units (RSUs) on August 7, 2025.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, plans to sell 2,688 shares of common stock under a pre-arranged 10b5-1 trading plan.

CareDx, Inc.'s Secretary and General Counsel, Jeffrey Adam Novack, had 2,873 shares withheld to cover tax obligations related to restricted stock unit vesting.

CareDx Chief Financial Officer Abhishek Jain disposed of 7,687 common shares to cover tax obligations from restricted stock unit vesting.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported a routine disposition of 276 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

CareDx, Inc. Director Peter Maag sold 10,000 shares of common stock at a weighted average price of $18.5831 per share on July 7, 2025, pursuant to a Rule 10b5-1 trading plan.

CareDx, Inc. Director Michael Goldberg received an automatic quarterly grant of 1,218 shares of common stock as non-employee director compensation, increasing his total beneficial ownership to 154,216 shares.

Hannah Valantine, a Director at CareDx, Inc., sold 10,570 shares of common stock for approximately $202,500 through a pre-scheduled Rule 10b5-1 trading plan.

CareDx, Inc. Director Peter Maag sold 10,000 shares of common stock on June 17, 2025, at a weighted average price of $19.242 per share, pursuant to a Rule 10b5-1 trading plan.

CareDx, Inc. Director Michael Goldberg was granted 12,103 shares of common stock in the form of restricted stock units on June 13, 2025, as reported in a recent SEC Form 4 filing.

CareDx, Inc. Director Fred E. Cohen reported the acquisition of 12,103 restricted stock units, a non-cash transaction, effective June 13, 2025, increasing his direct beneficial ownership to 155,265 shares.

CareDx, Inc. Director Peter Maag was granted 12,103 shares of common stock in the form of Restricted Stock Units (RSUs) on June 13, 2025, as part of his compensation.

CareDx, Inc. Director Richard Bryan Riggsbee was granted 12,103 shares of common stock in the form of restricted stock units, vesting in 2026 or earlier, as part of his compensation.

CareDx, Inc. Director George Bickerstaff was granted 12,103 restricted stock units, increasing his beneficial ownership to 115,130 shares.